![Knockdown Validated: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Melatonin Receptor 1B Antibody [NLS932] - Analysis for collagen I, fibronectin, and Alpha-smooth muscle actin (Alpha-SMA). Cells were treated with TGF-B1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (0.1 mM or 1 mM) for 30 min. The graphs show the results of quantitative analysis of collagen I. Melatonin Prevents Transforming Growth Factor-B1 Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396/) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Western-Blot-NLS932-img0012.jpg "Knockdown Validated: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Melatonin Receptor 1B Antibody [NLS932] - Analysis for collagen I, fibronectin, and Alpha-smooth muscle actin (Alpha-SMA). Cells were treated with TGF-B1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (0.1 mM or 1 mM) for 30 min. The graphs show the results of quantitative analysis of collagen I. Melatonin Prevents Transforming Growth Factor-B1 Stimulated Transdifferentiation of Renal Interstitial Fibroblasts to Myofibroblasts by Suppressing Reactive Oxygen Species-Dependent Mechanisms. Image collected and cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396/) licensed under a CC-BY license.")
| Reactivity | Hu, Mu, Rt, ChSpecies Glossary |
| Applications | WB, IHC, KD |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 1 mg/ml |
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Alexa Fluor 405 | NLS932AF405 | |||
| Alexa Fluor 488 | NLS932AF488 | |||
| Alexa Fluor 647 | NLS932AF647 | |||
| Alexa Fluor 700 | NLS932AF700 | |||
| Biotin | NLS932B | |||
| DyLight 405 | NLS932V | |||
| DyLight 488 | NLS932G | |||
| DyLight 550 | NLS932R | |||
| DyLight 650 | NLS932C | |||
| FITC | NLS932F | |||
| HRP | NLS932H | |||
| Immunogen | A synthetic peptide made to an internal region of the human Melatonin Receptor 1B protein (within residues 200-300) [Swiss-Prot P49286]. |
| Localization | Cell membrane; Multi-pass membrane protein. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | MTNR1B |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
||
| Application Notes | Prior to immunostaining paraffin tissues, antigen retrieval with sodium citrate buffer (pH 6.0) is recommended. |
||
| Control Peptide |
|
||
| Reviewed Applications |
|
||
| Publications |
|
| Storage | Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
| Buffer | PBS and 30% Glycerol |
| Preservative | 0.05% Sodium Azide |
| Concentration | 1 mg/ml |
| Purity | Immunogen affinity purified |
![Western Blot Serotonin N-acetyltransferase [p Thr29] Antibody - BSA Free](https://images.novusbio.com/images/Serotonin-N-acetyltransferase-[p-Thr29]-Antibody-Western-Blot-NB120-3439-img0003.jpg)
| Images | Ratings | Applications | Species | Date | Details | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-(005-ml)_NLS932_9786.png)
Enlarge |
reviewed by:
Verified Customer |
IHC-P | Rat | 09/03/2014 |
Summary
|
Secondary Antibodies |
Isotype Controls |
Research Areas for Melatonin Receptor 1B Antibody (NLS932)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Melatonin receptor type 1 B (MTR1B) in rat tissues fixed in paraformaldehyde and embedded in paraffin. A,B-brain, C-prostate. Image from verified customer review.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0008.jpg "Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Melatonin receptor type 1 B (MTR1B) in rat tissues fixed in paraformaldehyde and embedded in paraffin. A,B-brain, C-prostate. Image from verified customer review.")
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term diabetic treated with MLT (MD1) Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0009.jpg "Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term diabetic treated with MLT (MD1) Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)")
![Western Blot: Melatonin Receptor 1B Antibody [NLS932] - Analysis of 1) HepG2 and 2) A431.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Western-Blot-NLS932-img0003.jpg "Western Blot: Melatonin Receptor 1B Antibody [NLS932] - Analysis of 1) HepG2 and 2) A431.")
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term control (C1). Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0011.jpg "Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term control (C1). Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)")
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Analysis of Human Brain. 8 ug/ ml.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0006.jpg "Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Analysis of Human Brain. 8 ug/ ml.")
![Immunohistochemistry: Melatonin Receptor 1B Antibody [NLS932] - Analysis of Human Brain using Fast Red with hematoxylin counterstain.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-NLS932-img0004.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody [NLS932] - Analysis of Human Brain using Fast Red with hematoxylin counterstain.")
![Immunohistochemistry: Melatonin Receptor 1B Antibody [NLS932] - Staining of Mouse Brain.](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-NLS932-img0005.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody [NLS932] - Staining of Mouse Brain.")
![Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term control treated with MLT (M1). Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)](http://images.novusbio.com/fullsize/Melatonin-Receptor-1B-Antibody-Immunohistochemistry-Paraffin-NLS932-img0010.jpg "Immunohistochemistry-Paraffin: Melatonin Receptor 1B Antibody [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. Short-term control treated with MLT (M1). Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015)")
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416114744.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416114737.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416121978.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Western Blot: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Effects of luzindole on inhibitory action of melatonin on TGF-beta 1-stimulated proliferation & activation in renal interstitial fibroblasts. (A) Reverse transcription-polymerase chain reaction analysis of melatonin receptor type 1A (MT1) & type 1B (MT2) in NRK-49F cells. (B) NRK-49F cells were treated with with TGF-beta 1 (5 ng/mL) after preincubation with vehicle (Veh) or melatonin (Mel; 1mM) in the presence or absence of luzindole (Luz; 100 μM) for 30 min. Cell viability was assessed using CCK-8 assay at 0, 24, & 48 h. The OD was measured at 450 nm. (C) Western blot analysis for alpha -SMA & p-Smad2/3. Cells were treated with TGF-beta 1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (1 mM) in the presence or absence of luzindole (Luz; 20 μM or 100 μM) for 30 min. The graphs show the results of quantitative analysis of alpha -SMA (D) & p-Smad2/3 (E). ** p < 0.01 & *** p < 0.001 vs. Veh-treated cells. #p < 0.05 vs. TGF-beta 1-treated cells. NS: not significant. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-3102024161367.jpg "Western Blot: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Effects of luzindole on inhibitory action of melatonin on TGF-beta 1-stimulated proliferation & activation in renal interstitial fibroblasts. (A) Reverse transcription-polymerase chain reaction analysis of melatonin receptor type 1A (MT1) & type 1B (MT2) in NRK-49F cells. (B) NRK-49F cells were treated with with TGF-beta 1 (5 ng/mL) after preincubation with vehicle (Veh) or melatonin (Mel; 1mM) in the presence or absence of luzindole (Luz; 100 μM) for 30 min. Cell viability was assessed using CCK-8 assay at 0, 24, & 48 h. The OD was measured at 450 nm. (C) Western blot analysis for alpha -SMA & p-Smad2/3. Cells were treated with TGF-beta 1 (5 ng/mL) for 24 h after preincubation with Veh or Mel (1 mM) in the presence or absence of luzindole (Luz; 20 μM or 100 μM) for 30 min. The graphs show the results of quantitative analysis of alpha -SMA (D) & p-Smad2/3 (E). ** p < 0.01 & *** p < 0.001 vs. Veh-treated cells. #p < 0.05 vs. TGF-beta 1-treated cells. NS: not significant. Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/31906396), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.](http://images.novusbio.com/fullsize/nls932_rabbit-polyclonal-melatonin-receptor-1b-antibody-310202416121951.jpg "Immunohistochemistry: Melatonin Receptor 1B Antibody - BSA Free [NLS932] - Tissue localization of melatonin receptor type 1B (MTR1B) in the ventral prostate of rats. (a) Short-term control (C1); (b) short-term control treated with MLT (M1); (c) short-term untreated diabetic (D1); (d) short-term diabetic treated with MLT (MD1); (e) long-term control (C2); (f) long-term control treated with MLT (M2); (g) long-term untreated diabetic (D2); (h) long-term diabetic treated with MLT (MD2). (i) Negative control; (j) positive control, brain tissue section of rat. (k) Relative frequency (%) for MTR1B-positive areas. e: epithelium; l: lumen; s: stroma. Magnification: 400x, bar = 25 μm. Light bars: short-term experiment & dark bars: long-term experiment (N = 5 animals/group). Different lowercase letters indicate significant differences between experimental groups C1, M1, D1, & MD1 (nonparametric data), & different capital letters indicate significant differences between groups C2, M2, D2, & MD2 (parametric data), according to ANOVA followed by the Tukey (post hoc) or Kruskal-Wallis test followed by Dunn's test (post hoc). Image collected & cropped by CiteAb from the following publication (//pubmed.ncbi.nlm.nih.gov/26295055), licensed under a CC-BY license. Not internally tested by Novus Biologicals.")
![Immunocytochemistry Insulin Antibody (182410) [Unconjugated]](https://images.novusbio.com/images2/Insulin_MAB1417_Immunocytochemistry_9376.jpg)
![Immunohistochemistry Insulin Antibody (182410) [Unconjugated]](https://images.novusbio.com/images2/mab1417_human-bovine-mouse-insulin-mab-clone-182410-immunohistochemistry-308202115145.jpg)
![Bioactivity CTLA-4 [Unconjugated]](https://images.novusbio.com/images2/CTLA4_7268CT_2293.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")
-(005-ml)_NLS932_9786.png)